Cargando…
IgY Antibodies as Biotherapeutics in Biomedicine
Since the discovery of antibodies by Emil Von Behring and Shibasaburo Kitasato during the 19th century, their potential for use as biotechnological reagents has been exploited in different fields, such as basic and applied research, diagnosis, and the treatment of multiple diseases. Antibodies are r...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590010/ https://www.ncbi.nlm.nih.gov/pubmed/36278615 http://dx.doi.org/10.3390/antib11040062 |
_version_ | 1784814421035450368 |
---|---|
author | León-Núñez, Diana Vizcaíno-López, María Fernanda Escorcia, Magdalena Correa, Dolores Pérez-Hernández, Elizabeth Gómez-Chávez, Fernando |
author_facet | León-Núñez, Diana Vizcaíno-López, María Fernanda Escorcia, Magdalena Correa, Dolores Pérez-Hernández, Elizabeth Gómez-Chávez, Fernando |
author_sort | León-Núñez, Diana |
collection | PubMed |
description | Since the discovery of antibodies by Emil Von Behring and Shibasaburo Kitasato during the 19th century, their potential for use as biotechnological reagents has been exploited in different fields, such as basic and applied research, diagnosis, and the treatment of multiple diseases. Antibodies are relatively easy to obtain from any species with an adaptive immune system, but birds are animals characterized by relatively easy care and maintenance. In addition, the antibodies they produce can be purified from the egg yolk, allowing a system for obtaining them without performing invasive practices, which favors the three “rs” of animal care in experimentation, i.e., replacing, reducing, and refining. In this work, we carry out a brief descriptive review of the most outstanding characteristics of so-called “IgY technology” and the use of IgY antibodies from birds for basic experimentation, diagnosis, and treatment of human beings and animals. |
format | Online Article Text |
id | pubmed-9590010 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95900102022-10-25 IgY Antibodies as Biotherapeutics in Biomedicine León-Núñez, Diana Vizcaíno-López, María Fernanda Escorcia, Magdalena Correa, Dolores Pérez-Hernández, Elizabeth Gómez-Chávez, Fernando Antibodies (Basel) Review Since the discovery of antibodies by Emil Von Behring and Shibasaburo Kitasato during the 19th century, their potential for use as biotechnological reagents has been exploited in different fields, such as basic and applied research, diagnosis, and the treatment of multiple diseases. Antibodies are relatively easy to obtain from any species with an adaptive immune system, but birds are animals characterized by relatively easy care and maintenance. In addition, the antibodies they produce can be purified from the egg yolk, allowing a system for obtaining them without performing invasive practices, which favors the three “rs” of animal care in experimentation, i.e., replacing, reducing, and refining. In this work, we carry out a brief descriptive review of the most outstanding characteristics of so-called “IgY technology” and the use of IgY antibodies from birds for basic experimentation, diagnosis, and treatment of human beings and animals. MDPI 2022-09-29 /pmc/articles/PMC9590010/ /pubmed/36278615 http://dx.doi.org/10.3390/antib11040062 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review León-Núñez, Diana Vizcaíno-López, María Fernanda Escorcia, Magdalena Correa, Dolores Pérez-Hernández, Elizabeth Gómez-Chávez, Fernando IgY Antibodies as Biotherapeutics in Biomedicine |
title | IgY Antibodies as Biotherapeutics in Biomedicine |
title_full | IgY Antibodies as Biotherapeutics in Biomedicine |
title_fullStr | IgY Antibodies as Biotherapeutics in Biomedicine |
title_full_unstemmed | IgY Antibodies as Biotherapeutics in Biomedicine |
title_short | IgY Antibodies as Biotherapeutics in Biomedicine |
title_sort | igy antibodies as biotherapeutics in biomedicine |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590010/ https://www.ncbi.nlm.nih.gov/pubmed/36278615 http://dx.doi.org/10.3390/antib11040062 |
work_keys_str_mv | AT leonnunezdiana igyantibodiesasbiotherapeuticsinbiomedicine AT vizcainolopezmariafernanda igyantibodiesasbiotherapeuticsinbiomedicine AT escorciamagdalena igyantibodiesasbiotherapeuticsinbiomedicine AT correadolores igyantibodiesasbiotherapeuticsinbiomedicine AT perezhernandezelizabeth igyantibodiesasbiotherapeuticsinbiomedicine AT gomezchavezfernando igyantibodiesasbiotherapeuticsinbiomedicine |